£128.47

Recent Approaches For The Treatment Of Alzheimer’s Disease

Price data last checked 154 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£128 today · cheaper than every other day in the last 24 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 577 days • 577 data points (No recent data available)

Historical
Generating forecast...
£128.47 £122.05 £124.62 £127.19 £129.75 £132.32 £134.89 09 June 2024 31 October 2024 24 March 2025 15 August 2025 06 January 2026

Price Distribution

Price distribution over 577 days • 1 price levels

Days at Price
577 days 0 144 289 433 577 £128 Days at Price

Price Analysis

Most common price: £128 (577 days, 100.0%)

Price range: £128 - £128

Price levels: 1 different prices over 577 days

Description

Today most of the people in the world now have suffered from Alzheimer’s disease. Alzheimer’s destroys brain cells, causing problems with memory, thinking and behavior severe enough to affect work, lifelong hobbies or social life. Alzheimer’s gets worse over time, and it is fatal. Today it is the seventh-leading cause of death in the world. Today one cannot depend on the single drug for the treatment of Alzheimer’s disease. There are many drug therapies for the treatment of AD. Additionally, screening and early diagnosis provides an avenue for trial of the new range of medications with some potential for slowing progression of some dementias. For all of these reasons, screening people reporting loss of memory is a valuable approach to promote. The primary goals of treatment of patients with AD are to improve quality of life and maximize functional performance by enhancing cognition, mood, and behavior. Treatments include pharmacologic and non-pharmacologic approaches. Drugs such as Tacrine, Donepezil, Rivastigmine, selegiline, valproate, memantine, clioquinol and various antioxidants are used to improve the quality of life. Therefore, the pharmaceutical formulations with combination of drugs have shown an increasing trend to counteract other symptoms specific to one drug formulations hence analytical chemist will have to accept the challenges of developing reliable methods for the analysis of drugs in such formulations.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
21 February 2021
Listed Since
22 February 2021

Barcode

No barcode data available

Similar Products You Might Like

Practical Pharmacology for Alzheimer’s Disease
97% match

Practical Pharmacology for Alzheimer’s Disease

Springer

£109.99 12 Apr 2026
Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics
97% match

Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics

Springer

£81.52 28 Feb 2026
Practical Pharmacology for Alzheimer’s Disease
97% match

Practical Pharmacology for Alzheimer’s Disease

Springer

£77.23 12 Apr 2026
Developing Therapeutics for Alzheimer's Disease: Progress and Challenges
96% match

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Academic Press

£90.48 23 Feb 2026
Neuroprotection in Alzheimer's Disease
96% match

Neuroprotection in Alzheimer's Disease

Academic Press

£85.71 11 Mar 2026
Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)
96% match

Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)

Humana

£84.24 09 Mar 2026
The Biology of Alzheimer Disease (Cold Spring Harbor Perspectives in Medicine)
96% match

The Biology of Alzheimer Disease (Cold Spring Harbor Perspectives in Medicine)

Cold Spring Harbor Laboratory Press

£81.68 13 Jan 2026
Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4
96% match

Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4

£13.02 28 Feb 2026
Computational and Experimental Studies in Alzheimer's Disease
96% match

Computational and Experimental Studies in Alzheimer's Disease

£107.98 20 Jan 2026
Alzheimer's Disease and Related Disorders: Etiology, Pathogenesis and Therapeutics
96% match

Alzheimer's Disease and Related Disorders: Etiology, Pathogenesis and Therapeutics

£114.84 12 Dec 2025
Ageing and Dementia: 53 (Journal of Neural Transmission. Supplementa, 53)
96% match

Ageing and Dementia: 53 (Journal of Neural Transmission. Supplementa, 53)

Springer

£170.65 12 Jan 2026
Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)
96% match

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

CRC Press

£87.80 09 Mar 2026
Research Progress in Alzheimer's Disease and Dementia, Volume 2: v. 2
96% match

Research Progress in Alzheimer's Disease and Dementia, Volume 2: v. 2

£97.65 09 Mar 2026
Molecular Mechanisms of Dementia (Contemporary Neuroscience)
96% match

Molecular Mechanisms of Dementia (Contemporary Neuroscience)

Humana

£70.47 09 Apr 2026
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease
96% match

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Academic Press

£52.49 21 Feb 2026
Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)
96% match

Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Humana

£143.46 23 Jan 2026
The End of Alzheimer's: The Brain and Beyond
96% match

The End of Alzheimer's: The Brain and Beyond

Academic Press

£49.87 05 Mar 2026
Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations
96% match

Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations

Wiley

£207.59 10 Feb 2026
Alzheimer's Disease Drug Development: Research and Development Ecosystem
96% match

Alzheimer's Disease Drug Development: Research and Development Ecosystem

Cambridge University Press

£92.49 01 Feb 2026
Handbook of Neuropsychology, 2nd Edition: Aging and Dementia (Volume 6) (Handbook of Neuropsychology, Volume 6)
96% match

Handbook of Neuropsychology, 2nd Edition: Aging and Dementia (Volume 6) (Handbook of Neuropsychology, Volume 6)

Elsevier

£65.45 28 Feb 2026
ALZHEIMER'S DISEASE: INSIGHTS INTO LOW MOLECULAR WEIGHT AND CYTOTOXIC AGGREGATES FROM IN VITRO AND COMPUTER EXPERIMENTS - MOLECULAR BASIS OF ... (Molecular Medicine And Medicinal Chemistry)
96% match

ALZHEIMER'S DISEASE: INSIGHTS INTO LOW MOLECULAR WEIGHT AND CYTOTOXIC AGGREGATES FROM IN VITRO AND COMPUTER EXPERIMENTS - MOLECULAR BASIS OF ... (Molecular Medicine And Medicinal Chemistry)

Imperial College Press

£71.35 16 Feb 2026
Young-Onset Dementias, An Issue of Psychiatric Clinics of North America (Volume 38-2) (The Clinics: Internal Medicine, Volume 38-2)
96% match

Young-Onset Dementias, An Issue of Psychiatric Clinics of North America (Volume 38-2) (The Clinics: Internal Medicine, Volume 38-2)

Elsevier

£54.77 12 Feb 2026
Biomarkers for Early Diagnosis of Alzheimer's Disease
96% match

Biomarkers for Early Diagnosis of Alzheimer's Disease

£67.65 11 Mar 2026
Alzheimer's Disease: 2 (Topics in Medicinal Chemistry, 2)
96% match

Alzheimer's Disease: 2 (Topics in Medicinal Chemistry, 2)

Springer

£130.74 10 Mar 2026